AXTI Falls Below 50-Day SMA: Is It Time to Hold or Exit the Stock?
AXT's drop below its 50-day SMA reflects export delays and cash-flow risks, but record InP backlog and AI demand support retaining the stock.
AXTI Ramps Up InP Capacity: Is Multi-Year Growth Taking Shape?
AXT is accelerating InP capacity expansion through 2028 as AI optical demand, a $100M-plus backlog and Tier-1 adoption point to multi-year growth.
AXT's China AI Opportunity: Hidden Growth Driver or Geopolitical Risk?
AXTI's China AI demand is surging as indium phosphide sales jump, but rising geopolitical tensions could shape its next growth phase.
Can AXTI Deliver Its Biggest Indium Phosphide Quarter Ever?
AXTI could post its biggest-ever Indium Phosphide quarter in Q2 2026 as AI demand surges and a record backlog boosts revenue visibility.
Can AXTI Capitalize on the Optical Networking Upgrade Cycle?
AXT is riding on the AI-driven optical networking boom as rising InP demand, capacity expansion, and a $100M backlog position it for long-term growth.
AXT's $100M Backlog Sounds Bullish, But Can Export Risks Derail Growth?
AXT's indium phosphide backlog tops $100M as AI-driven demand surges, but export approvals remain the key factor shaping growth.
AXT's Order Backlog Surge & Capacity Push Fuel Growth Expectations
AXTI's backlog tops $100M as AI-driven indium phosphide demand surges, with capacity set to double in 2026 and again in 2027.
AXTI's Capacity Expansion: Will It Cement AI Supply-Chain Leadership?
AXTI plans to quadruple indium phosphide capacity by 2027, using existing facilities and vertical integration to meet rising AI demand.
Are You Looking for a Top Momentum Pick? Why AXT (AXTI) is a Great Choice
Does AXT (AXTI) have what it takes to be a top stock pick for momentum investors? Let's find out.
AXTI's AI-Driven Indium Phosphide Boom: Is Hypergrowth Sustainable?
AXT's AXTI first-quarter 2026 results suggest the company is rapidly emerging as a critical supplier to the AI optical infrastructure buildout, but the key debate now is whether execution can keep pace with demand. Indium phosphide revenue surged to $13.6 million in the first quarter, accounting for more than half of total company revenue and driven primarily by AI data center and optical transceiver applications.
AXT vs. Coherent: Which Photonics Chip Supplier Is the Better Buy?
AXTI is gaining momentum in AI photonics as record backlog, rising indium phosphide demand and capacity growth fuel its early-cycle story.
AXT: A Company Meeting An Inflection Point
AXT stands out as an undercovered AI infrastructure play following a strong Q1 2026 earnings report. AXTI's exposure to the AI boom, particularly through its role in GPU supply chains, positions it for significant upside. Despite widespread focus on high-profile AI names, AXTI's fundamentals and growth trajectory merit increased investor attention.
